Q Therapeutics, Inc. 4
4 · Q Therapeutics, Inc. · Filed Dec 22, 2014
Insider Transaction Report
Form 4
Q Therapeutics, Inc.[NONE]
EPPSTEIN DEBORAH ANNE
CEO & President, Director
Transactions
- Award
Option to Purchase Common Stock
2014-12-18$0.70/sh+300,000$210,000→ 2,608,071 totalExercise: $0.70From: 2015-01-31Exp: 2024-12-17→ Common Stock (300,000 underlying) - Award
Option to Purchase Common Stock
2014-12-18$0.70/sh+285,700$199,990→ 2,893,771 totalExercise: $0.70From: 2015-01-31Exp: 2024-12-17→ Common Stock (275,000 underlying)
Footnotes (2)
- [F1]Options to commence vesting beginning January 1, 2015, and will vest monthly in equal increments over 48 months.
- [F2]Grant relates to compensation resulting from the executive's salary deferral that occurred in 2014. All options fully vested upon grant.